Bob Doman

Board Member at Akari Therapeutics - New York, NY, US

Bob Doman's Contact Details
HQ
929-274-7510
Location
Greater Philadelphia Area
Company
Akari Therapeutics
Bob Doman's Company Details
Akari Therapeutics logo, Akari Therapeutics contact details

Akari Therapeutics

New York, NY, US • 20 - 49 Employees
BioTech/Drugs

Akari is a biopharmaceutical company focused on developing inhibitors of acute and chronic inflammation, specifically for the treatment of rare and orphan diseases, in particular those where the complement (C5) or leukotriene (LTB4) systems, or both complement and leukotrienes together, play a primary role in disease progression. Akari's lead drug candidate, nomacopan (formerly known as Coversin), is a C5 complement inhibitor that also independently and specifically inhibits leukotriene B4 (LTB4) activity.

Biotechnology Healthcare Pharmaceuticals
Details about Akari Therapeutics
Frequently Asked Questions about Bob Doman
Bob Doman currently works for Akari Therapeutics.
Bob Doman's role at Akari Therapeutics is Board Member.
Bob Doman's email address is ***@akaritx.com. To view Bob Doman's full email address, please signup to ConnectPlex.
Bob Doman works in the BioTech/Drugs industry.
Bob Doman's colleagues at Akari Therapeutics are Torsten Hombeck, Annie Mack, Naresh Sabharwal, Miles Nunn, Philip Stromeyer, Malakeh Mouh, Nekane Aspe and others.
Bob Doman's phone number is 929-274-7510
See more information about Bob Doman